Printer Friendly

UNITED-GUARDIAN SIGNS CONTRACT WITH BAKER NORTON PHARMACEUTICALS INC.

 HAUPPAUGE, N.Y., Nov. 17 ~PRNewswire~ -- United-Guardian, Inc. (AMEX: UG) announced today that it has appointed Baker Norton Pharmaceuticals Inc. as the exclusive distributor of Lubraseptic Jelly in the United States, Canada, Great Britain and Ireland. United- Guardian will supply Baker Norton Pharmaceuticals with its requirements of the products.
 Lubraseptic is not only an anesthetic but an antibacterial as well. As such, it is much more cost effective than the other anesthetic jellies. At a time when reducing medical costs is so important, the effectiveness of the product, combined with such a cost advantage, can be very advantageous.
 United-Guardian, which has marketed Lubraseptic as a medical anesthetic jelly for many years, expects that this agreement with Baker Norton Pharmaceuticals will increase sales of the product significantly in the first full year.
 United-Guardian is a manufacturer of pharmaceuticals, medical devices and healthcare products. Baker Norton Pharmaceuticals is a wholly owned subsidiary of Ivax Corp. (AMEX: IVX).
 -0- 11~17~92
 ~CONTACT: United-Guardian, Inc. public relations, 516-273-0900~
 (UG IVX)


CO: United-Guardian, Inc.; Ivax Corp. ST: New York IN: MTC SU: CON

SM-PS -- NY012 -- 1680 11~17~92 08:46 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 17, 1992
Words:188
Previous Article:BRITISH AIRWAYS MAINTAINS PROFIT MOMENTUM $199 MILLION NET PROFIT IN SECOND QUARTER,
Next Article:U.S. HEALTHCARE ANNOUNCES 39 PERCENT INCREASE IN CASH DIVIDEND
Topics:


Related Articles
IVAX ANNOUNCES JOINT DEVELOPMENT AGREEMENT WITH GLAXO
BAKER CUMMINS PHARMACEUTICALS CHANGES ITS NAME TO BAKER NORTON PHARMACEUTICALS
IVAX COMMENCES DISTRIBUTION OF VERAPAMIL
IVAX CONTINUES TO MANUFACTURE AND DISTRIBUTE VERAPAMIL
NEW JERSEY STATE FORMULARY APPROVES BAKER NORTON'S GENERIC VERAPAMIL
BAKER NORTON PHARMACEUTICALS RECEIVES LICENSE FROM BOSTON UNIVERSITY FOR METHOD TO TREAT CERTAIN INVOLUNTARY MOVEMENT DISORDERS
IVAX ANNOUNCES THE APPROVAL OF ELMIRON(R) IN CANADA
IVAX ANNOUNCES STRATEGIC ALLIANCE WITH NAPRO BIOTHERAPEUTICS REGARDING TAXOL
IVAX SUBSIDIARY GRANTED APPROVAL TO MARKET BECLOMETHASONE MET RED DOSE INHALER IN U.K.
IVAX ANNOUNCES RESULTS OF ANNUAL MEETING AND PROMOTION OF DR. JOHN K. WHISNANT

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters